Change at the top for Biogen after Alzheimer’s drug flops
Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer’s drug Aduhelm less ...
Read moreBiogen will replace its CEO and largely abandon marketing of its controversial Alzheimer’s drug Aduhelm less ...
Read moreWASHINGTON — U.S. health secretary Xavier Becerra on Monday ordered Medicare to reassess a big premium ...
Read moreBiogen is slashing the price of its Alzheimer’s treatment in half months after it debuted to ...
Read more